节点文献

SA/mIL15双功能融合蛋白的制备及其生物学鉴定

Preparation and bioactivity evaluation of SA-mIL15 fusing protein

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈艳丽许晓玲唐佳聂小霞宋志纯胡志明高基民

【Author】 CHEN Yan-li1,XU Xiao-ling1,TANG Jia1,NIE Xiao-xia1,SONG Zhi-chun1,HU Zhi-min2,GAO Ji-min1,21Zhejiang Provincial Key Laboratory of Medical Genetics,Wenzhou Medical College,Wenzhou 325035;2Institute of Biotherapy,School of Biotechnology,Southern Medical University,Guangzhou 510515,China

【机构】 温州医学院浙江省医学遗传学重点实验室南方医科大学生物技术学院生物治疗研究所

【摘要】 目的:制备链亲和素(SA)标记的鼠白细胞介素-15融合蛋白SA-mIL15和mIL15-SA,并研究其生物学功能。方法:构建pET24a-SA-L-mIL15和pET21a-mIL15-L-SA重组表达质粒,在大肠杆菌中表达融合蛋白SA-mIL15和mIL15-SA,对所表达的蛋白分别采用镍金属螯合(Ni-NTA)层析和阴离子交换(DEAE)层析进行纯化,透析复性。MTT法检测融合蛋白对ConA刺激的小鼠脾淋巴细胞增殖活性,流式细胞术(FCM)分析融合蛋白对生物素化的小鼠前列腺癌(RM-1)细胞表面锚定修饰效率。结果:SA-mIL15和mIL15-SA在大肠杆菌中实现了高效表达,约占细菌总蛋白的20%。制备的SA-mIL15和mIL15-SA融合蛋白纯度达到95%,并具有双重活性,即:mIL15促进ConA激活的小鼠脾淋巴细胞的增殖活性和SA介导的高效结合至表面已生物素化的RM-1细胞的功能(表面锚定修饰效率均大于95%)。其中,SA-mIL15双功能融合蛋白促进ConA激活的小鼠脾淋巴细胞增殖活性为1×106IU/mg,mIL15-SA活性为2×105IU/mg。结论:SA/mIL15双功能融合蛋白具有双重活性,为mIL15表面锚定修饰的肿瘤细胞疫苗的研制奠定了基础。

【Abstract】 AIM:To prepare and characterize streptavidin-tagged murine interleukin-15 fusion proteins.METHODS:pET24a-SA-L-mIL15 and pET21a-mIL15-L-SA plasmids were constructed and expressed in Rosetta(DE3) host bacteria to generate SA/mIL15 fusion proteins.SA-mIL15 fusion protein was purified through the Ni-NTA affinity chromatography,and mIL15-SA fusion protein through anion exchange chromatography,followed by refolding.The efficiency of surface modification of the fusion proteins on the biotinylated RM-1 tumor cells was evaluated by a flow cytometer.MTT method was used to evaluate the proliferating effect of SA/mIL15 fusion proteins on mouse spleen lymphocytes stimulated by ConA.RESULTS:Both SA-mIL15 and mIL15-SA fusion proteins were highly expressed in Rosetta(DE3) at about 20% of total bacterial proteins.They exhibited the bi-functionality:proliferation-promoting activity of mIL15 on mouse spleen lymphocytes with the specific activity of 1×106 IU/mg for SA-mIL15 or 2×105 IU/mg for mIL15-SA,and SA-mediated high-affinity binding to the biotinylated surfaces of RM-1 tumor cells with about 95% surface modification efficiency.CONCLUSION:SA/mIL15 bi-functional fusion proteins were generated,which made feasible the development of mIL15-surtface-modified cancer cell vaccine.

【基金】 国家高技术研究发展计划(863)资助项目(2006AA02Z4C4);浙江省自然科学基金资助项目(R2080407);浙江省科技计划重大专项资助项目(2008C14082)
  • 【文献出处】 细胞与分子免疫学杂志 ,Chinese Journal of Cellular and Molecular Immunology , 编辑部邮箱 ,2010年02期
  • 【分类号】R73-3
  • 【被引频次】1
  • 【下载频次】142
节点文献中: 

本文链接的文献网络图示:

本文的引文网络